Description
ABS-201 by Absci could be one of the most interesting investigational hair loss treatments to watch. This AI-designed anti-PRLR antibody is being studied for androgenetic alopecia, also known as male and female pattern hair loss. Could targeting the prolactin receptor open a new pathway for hair regrowth?
This is early-stage research, not an approved treatment — but the science is worth following.
Not medical advice. ABS-201 is investigational and not FDA-approved yet.
#ABS201 #Absci #HairLoss #HairLossTreatment #AndrogeneticAlopecia #PRLR #ProlactinReceptor #HairRegrowth #HairRestoration #AIDrugDiscovery #Balding #HairLossResearch #Minoxidil #HMI115 #Shorts